Struer, Denmark

Per Moelgaard Pedersen


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 2012-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Per Moelgaard Pedersen: Innovator in Injection Device Technology

Introduction

Per Moelgaard Pedersen is a notable inventor based in Struer, Denmark. He has made significant contributions to the field of medical devices, particularly in the development of injection devices. With a total of 2 patents to his name, his work focuses on enhancing the functionality and precision of injection technologies.

Latest Patents

One of his latest patents is an injection device comprising an optical sensor. This invention relates to an injection device that utilizes an optically-based sensor to determine the position or setting of a dose setting member. The device features a rotatably mounted member with multiple optically coded paths on its outer surface. This member is operatively connected to the dose setting member and is designed to rotate in conjunction with it. This innovation aims to improve the accuracy of dose delivery in medical applications.

Career Highlights

Per Moelgaard Pedersen is currently employed at Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk has allowed him to focus on developing advanced medical technologies that improve patient care. His contributions have been instrumental in the evolution of injection devices, making them more user-friendly and efficient.

Collaborations

Throughout his career, Per has collaborated with several talented individuals, including Preben Mikael Nielsen and Bodo Von Munchow. These collaborations have fostered a creative environment that encourages innovation and the development of cutting-edge technologies.

Conclusion

Per Moelgaard Pedersen is a distinguished inventor whose work in injection device technology has made a significant impact in the medical field. His innovative patents and contributions to Novo Nordisk A/S highlight his commitment to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…